Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Scopolamine Patch Treatment Report
What is Scopolamine Patch?

Scopolamine, also known as hyoscine, is available as a transdermal patch called Transderm ScopĀ®. It comes in 1.5 mg dose that releases about 1 mg over a 72 hours period to reduce excessive saliva and oral secretions.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Excess saliva 18 1
Drooling 2 1
Other 1 1
dry secretions 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 33%
Moderate
0 0%
Mild
0 0%
None
2 67%

Most commonly reported side effects

Skin irritation
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

  1.5mg as needed daily 1.5 mg weekly 0.5 mg daily 1.5 mg daily 5 g daily
  3 Number of Patients: 3 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Scopolamine Patch (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
5 56% Did not seem to work: 56%
Side effects too severe
3 33% Side effects too severe: 33%
Other
1 11% Other: 11%
Not indicated
1 11% Not indicated: 11%

See all 9 patients who’ve stopped taking Scopolamine Patch

Currently Taking Scopolamine Patch

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
4
1
1

Stopped Taking Scopolamine Patch

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
3
2
1
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 33%
Usually
2 67%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
3 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
3 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.